文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新冠病毒感染作为艾滋病毒/艾滋病患者口腔念珠菌病的一个加重因素

COVID-19 Infection as an Exacerbated Factor of Oral Candidiasis in HIV/AIDS Patient.

作者信息

Hapid M Hasan, Dewi Tenny Setiani

机构信息

Oral Medicine Department, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia.

出版信息

Int Med Case Rep J. 2023 May 18;16:303-310. doi: 10.2147/IMCRJ.S407597. eCollection 2023.


DOI:10.2147/IMCRJ.S407597
PMID:37228898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10203351/
Abstract

INTRODUCTION: Oral candidiasis is an oral mucosal infection caused by sp. This infection can appear in patients with HIV/AIDS associated with immunodeficiency. Another factor that can aggravate the occurrence of oral candidiasis is the COVID-19 infection caused by the SARS-CoV-2 virus as a current pandemic condition. This case report aims to explain the mechanism of COVID-19 infection as a factor that can aggravate the condition of oral candidiasis in HIV/AIDS patients. CASE: A 56-year-old male patient was consulted from the COVID-19 isolation unit to the Department of Oral Medicine with complaints of sore and uncomfortable mouth related to white plaque covering the surface of the tongue. The patient was diagnosed with HIV/AIDS and had a COVID-19 infection. The management instructions were to maintain oral hygiene, administration of antifungal drugs such as nystatin oral suspension and fluconazole, chlorhexidine gluconate 0.2% mouthwash, and vaseline album. DISCUSSION: Generally, HIV/AIDS patient has dysregulation of the immune system which can suppress host immunity to fight pathogens, making it easy for opportunistic infections such as oral candidiasis. The COVID-19 infection can cause lymphopenia conditions that further reduce the host's ability to fight pathogens. The SARS-CoV-2 virus can also directly attack various tissues in the oral mucosa which can contribute to exacerbating the severity of oral candidiasis in HIV/AIDS patients. CONCLUSION: The COVID-19 infection is a factor that can exacerbate the condition of oral candidiasis in HIV/AIDS patients by further decreasing the host's immunity and damaging various tissues in the oral mucosa.

摘要

引言:口腔念珠菌病是由念珠菌属引起的口腔黏膜感染。这种感染可出现在与免疫缺陷相关的艾滋病毒/艾滋病患者中。另一个可加重口腔念珠菌病发生的因素是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒引起的2019冠状病毒病(COVID-19)感染,这是当前的大流行疾病。本病例报告旨在解释COVID-19感染作为加重艾滋病毒/艾滋病患者口腔念珠菌病病情的一个因素的机制。 病例:一名56岁男性患者从COVID-19隔离病房被转诊至口腔医学科,主诉口腔疼痛且不适,舌面有白色斑块。该患者被诊断为艾滋病毒/艾滋病且感染了COVID-19。处理指示为保持口腔卫生,给予抗真菌药物如制霉菌素口服混悬液和氟康唑、0.2%葡萄糖酸氯己定漱口水以及凡士林。 讨论:一般来说,艾滋病毒/艾滋病患者存在免疫系统失调,可抑制宿主抵抗病原体的免疫力,从而容易发生如口腔念珠菌病等机会性感染。COVID-19感染可导致淋巴细胞减少,进一步降低宿主抵抗病原体的能力。SARS-CoV-2病毒还可直接攻击口腔黏膜中的各种组织,这可能导致艾滋病毒/艾滋病患者口腔念珠菌病的严重程度加剧。 结论:COVID-19感染是一个可通过进一步降低宿主免疫力和损害口腔黏膜中的各种组织来加重艾滋病毒/艾滋病患者口腔念珠菌病病情的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/5238b64c3b94/IMCRJ-16-303-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/cbb8c915d5c2/IMCRJ-16-303-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/19bb8d29095b/IMCRJ-16-303-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/43b4bb931da7/IMCRJ-16-303-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/5238b64c3b94/IMCRJ-16-303-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/cbb8c915d5c2/IMCRJ-16-303-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/19bb8d29095b/IMCRJ-16-303-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/43b4bb931da7/IMCRJ-16-303-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1872/10203351/5238b64c3b94/IMCRJ-16-303-g0004.jpg

相似文献

[1]
COVID-19 Infection as an Exacerbated Factor of Oral Candidiasis in HIV/AIDS Patient.

Int Med Case Rep J. 2023-5-18

[2]
The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.

Pan Afr Med J. 2020-5-19

[3]
Clinical Assessment and Management in Improving the Quality of Life of HIV/AIDS Patients with Oral Candidiasis: A Case Series.

HIV AIDS (Auckl). 2023-11-14

[4]
Case Series of HIV-Associated Oral Lesions Among Antiretroviral-Naive Patients During the COVID-19 Pandemic.

Int Med Case Rep J. 2023-1-30

[5]
[Esophageal pathology in patients with the AIDS virus. Etiology and diagnosis].

Acta Gastroenterol Latinoam. 1991

[6]
Transfusion-acquired AIDS in Taiwan.

J Formos Med Assoc. 1996-1

[7]
Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.

HIV Clin Trials. 2000

[8]
Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand.

J Oral Pathol Med. 1998-1

[9]
Quantification of oral palatine Langerhans cells in HIV/AIDS associated oral Kaposi sarcoma with and without oral candidiasis.

J Cancer Res Ther. 2016

[10]
oropharyngeal infection in a patient with oral squamous cell carcinoma after COVID-19 infection.

Curr Med Mycol. 2023-9

本文引用的文献

[1]
Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis.

AIDS Res Ther. 2022-1-14

[2]
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.

Curr HIV/AIDS Rep. 2022-2

[3]
COVID-19 and HIV infection co-pandemics and their impact: a review of the literature.

AIDS Res Ther. 2021-5-5

[4]
Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.

J Clin Invest. 2021-6-15

[5]
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.

Front Immunol. 2020

[6]
Current uses of chlorhexidine for management of oral disease: a narrative review.

J Dent. 2020-12

[7]
The outbreak of COVID-19: An overview.

J Chin Med Assoc. 2020-3

[8]
Factors Associated with Oral Candidiasis in People Living with HIV/AIDS: A Case Control Study.

HIV AIDS (Auckl). 2020-1-14

[9]
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment.

J Lab Physicians. 2017

[10]
Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.

Drug Des Devel Ther. 2016-3-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索